Literature DB >> 9494704

The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis.

P P Hubain1, L Staner, M Dramaix, M Kerkhofs, G Papadimitriou, J Mendlewicz, P Linkowski.   

Abstract

BACKGROUND: The present study further examined relationships between postdexamethasone cortisol plasma values and sleep electroencephalogram (EEG) parameters.
METHODS: The dexamethasone suppression test (DST) and polysomnographic recordings were performed in a sample of 300 inpatients with primary major depressive disorder (MDD) (102 men and 198 women, mean age 44 +/- 12 years, range 20-74 years) consecutively admitted to Erasme Hospital (Brussels, Belgium) between 1981 and 1992.
RESULTS: The DST was abnormal in 40% of the sample. Postdexamethasone cortisol plasma values at 4:00 PM were significantly influenced by age, but not by gender. They were also significantly and positively correlated with weight loss, total scores on the Hamilton Depression Rating Scale, total scores on the Newcastle Scale, percentage of awakenings during sleep, and percent of stage 1. They were significantly and negatively correlated with percent of stage 2, slow-wave sleep, and REM sleep. Multiple regression analyses were conducted in two successive steps. First among clinical variables, only age and depressive symptom severity remained correlated with postdexamethasone plasma cortisol values. In the second step, with age and severity held constant, postdexamethasone plasma cortisol values were positively associated with amount of wake time and stage 1, and negatively with amount of slow-wave sleep.
CONCLUSIONS: These findings provide further indirect support for an overarousal state in MDD with sympathoadrenal system hyperactivity and impaired sleep continuity. They also underline the importance of taking into account various clinical confounding factors in the interpretation of both DST and sleep EEG results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494704     DOI: 10.1016/S0006-3223(97)80434-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

1.  Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.

Authors:  Michael E Thase; Harald Murck; Anke Post
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations.

Authors:  C Dugovic; S Maccari; L Weibel; F W Turek; O Van Reeth
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

3.  Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.

Authors:  Cornelius Schüle; Thomas Baghai; Peter Zwanzger; Robin Ella; Daniela Eser; Frank Padberg; Hans-Jürgen Möller; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

4.  Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.

Authors:  Jennifer C Felger; Ebrahim Haroon; Bobbi J Woolwine; Charles L Raison; Andrew H Miller
Journal:  Physiol Behav       Date:  2015-12-17

5.  Association of Depressive Symptoms with Sleep Disturbance: A Co-twin Control Study.

Authors:  Minxuan Huang; Donald L Bliwise; Martica H Hall; Dayna A Johnson; Richard P Sloan; Amit Shah; Jack Goldberg; Yi-An Ko; Nancy Murrah; Oleksiy M Levantsevych; Lucy Shallenberger; Rami Abdulbagki; J Douglas Bremner; Viola Vaccarino
Journal:  Ann Behav Med       Date:  2022-03-01

6.  Similar polysomnographic pattern in primary insomnia and major depression with objective insomnia: a sign of common pathophysiology?

Authors:  Matthieu Hein; Jean-Pol Lanquart; Gwénolé Loas; Philippe Hubain; Paul Linkowski
Journal:  BMC Psychiatry       Date:  2017-07-28       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.